CME Group Net Income
| CME Stock | USD 302.27 4.89 1.64% |
As of the 7th of February, CME shows the Mean Deviation of 0.8858, downside deviation of 1.29, and Risk Adjusted Performance of 0.1557. CME Group technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CME Group downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to decide if CME Group is priced adequately, providing market reflects its regular price of 302.27 per share. Given that CME has jensen alpha of 0.2054, we suggest you to validate CME Group's prevailing market performance to make sure the company can sustain itself in the future.
CME Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 16.2243 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 4.1 B | 4.3 B | |
| Net Income Applicable To Common Shares | 3.1 B | 3.2 B | |
| Net Income From Continuing Ops | 4.1 B | 2.5 B | |
| Net Income Per Share | 11.25 | 11.81 | |
| Net Income Per E B T | 0.76 | 0.57 |
CME | Net Income | Build AI portfolio with CME Stock |
Analyzing CME's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing CME's current valuation and future prospects.
Latest CME's Net Income Growth Pattern
Below is the plot of the Net Income of CME Group over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in CME Group financial statement analysis. It represents the amount of money remaining after all of CME Group operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is CME's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CME's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 3.53 B | 10 Years Trend |
|
Net Income |
| Timeline |
CME Net Income Regression Statistics
| Arithmetic Mean | 2,247,377,118 | |
| Coefficient Of Variation | 55.68 | |
| Mean Deviation | 1,023,785,903 | |
| Median | 2,105,200,000 | |
| Standard Deviation | 1,251,358,672 | |
| Sample Variance | 1565898.5T | |
| Range | 4.3B | |
| R-Value | 0.85 | |
| Mean Square Error | 453686.5T | |
| R-Squared | 0.73 | |
| Significance | 0.000013 | |
| Slope | 211,490,275 | |
| Total Sum of Squares | 25054376.4T |
CME Net Income History
Other Fundumenentals of CME Group
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
CME Net Income component correlations
CME Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for CME is extremely important. It helps to project a fair market value of CME Stock properly, considering its historical fundamentals such as Net Income. Since CME's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CME's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CME's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Financial Exchanges & Data sector continue expanding? Could CME diversify its offerings? Factors like these will boost the valuation of CME. Projected growth potential of CME fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CME data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.35 | Dividend Share 5 | Earnings Share 11.15 | Revenue Per Share | Quarterly Revenue Growth 0.089 |
CME Group's market price often diverges from its book value, the accounting figure shown on CME's balance sheet. Smart investors calculate CME's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CME's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between CME's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CME should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CME 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CME's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CME.
| 11/09/2025 |
| 02/07/2026 |
If you would invest 0.00 in CME on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding CME Group or generate 0.0% return on investment in CME over 90 days. CME is related to or competes with Intercontinental, Coinbase Global, Moodys, Bank of Montreal, Brookfield Asset, Mizuho Financial, and Nasdaq. CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futu... More
CME Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CME's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CME Group upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.29 | |||
| Information Ratio | 0.1115 | |||
| Maximum Drawdown | 5.09 | |||
| Value At Risk | (2.07) | |||
| Potential Upside | 1.99 |
CME Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CME's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CME's standard deviation. In reality, there are many statistical measures that can use CME historical prices to predict the future CME's volatility.| Risk Adjusted Performance | 0.1557 | |||
| Jensen Alpha | 0.2054 | |||
| Total Risk Alpha | 0.0942 | |||
| Sortino Ratio | 0.0995 | |||
| Treynor Ratio | 6.77 |
CME February 7, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1557 | |||
| Market Risk Adjusted Performance | 6.78 | |||
| Mean Deviation | 0.8858 | |||
| Semi Deviation | 1.02 | |||
| Downside Deviation | 1.29 | |||
| Coefficient Of Variation | 527.59 | |||
| Standard Deviation | 1.15 | |||
| Variance | 1.32 | |||
| Information Ratio | 0.1115 | |||
| Jensen Alpha | 0.2054 | |||
| Total Risk Alpha | 0.0942 | |||
| Sortino Ratio | 0.0995 | |||
| Treynor Ratio | 6.77 | |||
| Maximum Drawdown | 5.09 | |||
| Value At Risk | (2.07) | |||
| Potential Upside | 1.99 | |||
| Downside Variance | 1.66 | |||
| Semi Variance | 1.04 | |||
| Expected Short fall | (0.90) | |||
| Skewness | (0.39) | |||
| Kurtosis | 0.1649 |
CME Group Backtested Returns
At this point, CME is very steady. CME Group secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for CME Group, which you can use to evaluate the volatility of the firm. Please confirm CME's Risk Adjusted Performance of 0.1557, mean deviation of 0.8858, and Downside Deviation of 1.29 to double-check if the risk estimate we provide is consistent with the expected return of 0.16%. CME has a performance score of 10 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0307, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CME's returns are expected to increase less than the market. However, during the bear market, the loss of holding CME is expected to be smaller as well. CME Group at this time shows a risk of 1.16%. Please confirm CME Group treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to decide if CME Group will be following its price patterns.
Auto-correlation | -0.48 |
Modest reverse predictability
CME Group has modest reverse predictability. Overlapping area represents the amount of predictability between CME time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CME Group price movement. The serial correlation of -0.48 indicates that about 48.0% of current CME price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.48 | |
| Spearman Rank Test | -0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 99.68 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
CME Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, CME Group reported net income of 3.53 B. This is 176.0% higher than that of the Capital Markets sector and significantly higher than that of the Financials industry. The net income for all United States stocks is significantly lower than that of the firm.
CME Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CME's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CME could also be used in its relative valuation, which is a method of valuing CME by comparing valuation metrics of similar companies.CME is currently under evaluation in net income category among its peers.
CME ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CME's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CME's managers, analysts, and investors.Environmental | Governance | Social |
CME Institutional Holders
Institutional Holdings refers to the ownership stake in CME that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of CME's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing CME's value.| Shares | Capital Research & Mgmt Co - Division 3 | 2025-06-30 | 4.5 M | Fmr Inc | 2025-06-30 | 4 M | Arrowstreet Capital Limited Partnership | 2025-06-30 | 3.8 M | Northern Trust Corp | 2025-06-30 | 3.8 M | Gqg Partners Llc | 2025-06-30 | 3.6 M | Royal Bank Of Canada | 2025-06-30 | 3.4 M | Franklin Resources Inc | 2025-06-30 | 3.4 M | Fidelity International Ltd | 2025-06-30 | 3.2 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 3.1 M | Vanguard Group Inc | 2025-06-30 | 35.2 M | Blackrock Inc | 2025-06-30 | 30 M |
CME Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0157 | ||||
| Profit Margin | 0.62 % | ||||
| Operating Margin | 0.61 % | ||||
| Current Valuation | 105.79 B | ||||
| Shares Outstanding | 359.51 M | ||||
| Shares Owned By Insiders | 0.43 % | ||||
| Shares Owned By Institutions | 91.23 % | ||||
| Number Of Shares Shorted | 4.21 M | ||||
| Price To Earning | 32.83 X | ||||
| Price To Book | 3.72 X | ||||
| Price To Sales | 16.67 X | ||||
| Revenue | 6.52 B | ||||
| Gross Profit | 6.52 B | ||||
| EBITDA | 5.72 B | ||||
| Net Income | 3.53 B | ||||
| Cash And Equivalents | 2.22 B | ||||
| Cash Per Share | 6.19 X | ||||
| Total Debt | 3.42 B | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 1.02 X | ||||
| Book Value Per Share | 79.88 X | ||||
| Cash Flow From Operations | 3.69 B | ||||
| Short Ratio | 2.28 X | ||||
| Earnings Per Share | 11.15 X | ||||
| Price To Earnings To Growth | 5.56 X | ||||
| Target Price | 296.57 | ||||
| Number Of Employees | 3.76 K | ||||
| Beta | 0.28 | ||||
| Market Capitalization | 108.67 B | ||||
| Total Asset | 198.42 B | ||||
| Retained Earnings | 4.19 B | ||||
| Working Capital | 719.6 M | ||||
| Current Asset | 37.9 B | ||||
| Current Liabilities | 36.82 B | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.68 % | ||||
| Net Asset | 198.42 B | ||||
| Last Dividend Paid | 5.0 |
About CME Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CME Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CME using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CME Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:Check out You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Will Financial Exchanges & Data sector continue expanding? Could CME diversify its offerings? Factors like these will boost the valuation of CME. Projected growth potential of CME fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CME data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.35 | Dividend Share 5 | Earnings Share 11.15 | Revenue Per Share | Quarterly Revenue Growth 0.089 |
CME Group's market price often diverges from its book value, the accounting figure shown on CME's balance sheet. Smart investors calculate CME's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CME's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between CME's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CME should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.